Akathisia in Post Operative Outpatients Surgery

Akathisia Clinical Trial

Official title:
Etude de l'Effet du dropéridol et de l'Ondansetron Sur l'Incidence de l'Akathisie Post opératoire en Chirurgie Ambulatoire

Status Completed

Clinical Trial Summary

The main objective of this study is to evaluate the incidence of akathisia with Droperidol, the prophylactic treatment of post operative nausea and vomiting, used at two different doses, versus control group (Ondansetron), in outpatient surgery.The primary endpoint is to compare the number of observed akathisia (Barnes score > 1) in the Droperidol arms (0,625 mg and 1,25 mg) versus Ondansetron 4 hours after recovery from anesthesia.The assumption is that there is a greater risk of akathisia among patients taking Droperidol in prevention of NPVO, that among patients taking Ondansetron.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01942343
Study type	Interventional
Source	University Hospital, Strasbourg, France
Contact
Status	Completed
Phase	Phase 3
Start date	October 2013
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01069536` - Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide	N/A
Completed	`NCT01051271` - Prophylaxis Against Metoclopramide-Induced Akathisia	N/A
Completed	`NCT00065286` - Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation	Phase 3